Track the 에스티팜 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 에스티팜 has recorded 29 insider filings. The latest transaction was disclosed on 3 March 2026 (Other). Among the most active insiders: 동아쏘시오홀딩스. Every trade is openly available.
28
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
20 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Estipharm es una empresa especializada en el sector sanitario y farmacéutico, que cotiza en el mercado XKRX. Se centra en el desarrollo y la fabricación de productos farmacéuticos innovadores.